(Q37132894)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18398732%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Early interim PET scan in Hodgkin lymphoma: where do we stand? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18398732%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

Andrea Gallamini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18398732%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Abraham Avigdor

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18398732%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18398732%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18398732%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18398732%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18398732%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

659-662

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18398732%20AND%20SRC:MED&resulttype=core&format=json

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190801888704

Revised response criteria for malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801888704

Early therapy monitoring with FDG-PET in aggressive non-Hodgkin?s lymphoma and Hodgkin?s lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801888704

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801888704

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801888704

Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801888704

Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801888704

The role of cytokines in classical Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801888704

Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801888704

Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801888704

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801888704

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801888704

Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801888704

The disappearance of prognostic factors in Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801888704

Rituximab for the treatment of acquired antibodies to factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801888704

FDG PET and high-dose therapy for aggressive lymphomas: toward a risk-adapted strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801888704

Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801888704

10.1080/10428190801888704

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18398732%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference